Dimensional Fund Advisors
ALXO icon

Dimensional Fund Advisors’s ALX Oncology ALXO Stock Holding History

Dimensional Fund Advisors’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-26,233
Closed -$43.8K – 3323
2024
Q4 		$43.8K Sell
26,233
-11,413
-30% -$17.5K ﹤0.01% 3301
2024
Q3 		$68.8K Buy
37,646
+3,103
+9% +$11.5K ﹤0.01% 3268
2024
Q2 		$208K Sell
34,543
-15,798
-31% -$194K ﹤0.01% 3158
2024
Q1 		$561K Sell
50,341
-83,881
-62% -$1.18M ﹤0.01% 3026
2023
Q4 		$2M Sell
134,222
-517
-0.4% -$4.91K ﹤0.01% 2791
2023
Q3 		$647K Buy
134,739
+45,367
+51% +$246K ﹤0.01% 3011
2023
Q2 		$671K Sell
89,372
-3,040
-3% -$19.9K ﹤0.01% 3003
2023
Q1 		$418K Buy
92,412
+13,135
+17% +$99.5K ﹤0.01% 3067
2022
Q4 		$893 Buy
79,277
+12,804
+19% +$144K ﹤0.01% 2922
2022
Q3 		$636K Buy
+66,473
New +$775K ﹤0.01% 2989

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors's ALXO Position: Q1 2025 in Review

Dimensional Fund Advisors sold out of ALX Oncology (ALXO) in Q1 2025, closing a stake of 26,233 shares — an estimated $43.8K sold.

Dimensional Fund Advisors first reported a position in ALXO in Q3 2022 and held it in 10 quarters. The position peaked at $2M in Q4 2023. 85 funds tracked by Wall St. Rank hold ALXO as of Q1 2025.

  • Dimensional Fund Advisors reported no remaining ALX Oncology position as of Q1 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 26,233 ALX Oncology shares in Q1 2025, an estimated $43.8K.
  • Dimensional Fund Advisors first reported a position in ALX Oncology in Q3 2022 and held it in 10 quarters.
  • Dimensional Fund Advisors's ALX Oncology position peaked at $2M in Q4 2023.
  • 85 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2025.

Based on Dimensional Fund Advisors's 13F filing for Q1 2025, filed 13 May 2025.